Position in PFE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$5,618,802
-$927,740 QoQ
Shares Held
233,339
+0.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#567
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. PFE ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,876,785 | $723,914,175 | |
| 2 | LLY |
ELI LILLY & Co
|
425,688 | $510,582,998 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,664,909 | $213,940,806 | |
| 4 | JNJ |
Johnson & Johnson
|
688,542 | $174,869,011 | |
| 5 | NVO |
Novo Nordisk A S
|
2,924,500 | $140,200,529 | |
| 6 | AMGN |
Amgen Inc
|
54,394 | $19,697,155 | |
| 7 | PFE |
Pfizer Inc
This page
|
233,339 | $5,618,802 | |
| 8 | NVS |
Novartis AG
|
28,162 | $4,413,548 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,618,802 | 233,339 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $6,546,542 | 233,139 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,883,545 | 236,287 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,285,838 | 246,697 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,979,934 | 246,697 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,641,411 | 262,092 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $7,138,559 | 269,075 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,035,219 | 277,651 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,091,024 | 432,131 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,040,917 | 505,979 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $20,173,727 | 700,720 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $24,589,947 | 741,331 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $27,935,668 | 761,605 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $33,893,783 | 830,730 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $41,629,168 | 812,435 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $37,173,154 | 849,478 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $42,458,911 | 809,821 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $41,560,488 | 802,791 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $45,908,833 | 777,457 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $31,897,589 | 741,632 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $29,359,894 | 749,742 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $25,500,628 | 703,854 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $26,709,628 | 725,608 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $26,475,461 | 721,403 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $23,275,882 | 711,800 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $22,126,362 | 677,892 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||